CCTG IND.236: A Phase 1b trial of combined CFI-402257 and weekly paclitaxel in patients with HER2-negative (HER2-) advanced breast cancer (aBC)
Philippe Bedard,Mihaela Mates,John Hilton,Nathalie Levasseur,Arif Awan,Amirrtha Srikanthan,David W. Cescon,Karen Gelmon,Andrew Robinson, Nancy Drummond-Ivars,Irene Li,Laleh Rastgou,Jackie Edwards,Linda Hagerman,Siwei Zhang,Mark Bray,Lesley Seymour,Moira Rushton,Pierre-Olivier Gaudreau CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
